Niagen Bioscience, Inc. Common Stock (NASDAQ: NAGE) last traded at $2.69, up 1.13% on the session. The quote above updates while this page is open; the figures below are drawn from Niagen Bioscience, Inc. Common Stock’s own filings and are restated only when a new one is published.
Niagen Bioscience, Inc. Common Stock trades on NASDAQ under the ticker NAGE. Its market capitalisation is $212.85 million.
Valuation measures for Niagen Bioscience, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $212.85M |
|---|---|
| Enterprise value | $172.81M |
| P/E ratio | 14.94 |
| Price / sales | 1.65 |
| Price / book | 2.58 |
| Beta | 1.28 |
Trailing-twelve-month figures tagged in Niagen Bioscience, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $129.08M |
|---|---|
| Net income (TTM) | $15.99M |
| EPS (TTM) | $0.180 |
| Gross margin | 64.24% |
| Operating margin | 8.21% |
| Return on equity | 19.38% |
| Cash | $64.10M |
Range and volume for NAGE over the past 52 weeks.
| 52-week high | $7.95 |
|---|---|
| 52-week low | $2.61 |
| Volume | 268.1K |
| Average volume | 580.7K |
| Previous close | $2.66 |
Invest a chosen dollar amount in Niagen Bioscience, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell NAGE.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.